Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/F18112CC572C54ED4896CA2E29C728AE42B9DCBEEFC3BFEB4B72205303810671E2B2A8242E03A62BEC2DFCC98133C371http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F18112CC572C54ED4896CA2E29C728AE42B9DCBEEFC3BFEB4B72205303810671E2B2A8242E03A62BEC2DFCC98133C371http://www.w3.org/2000/01/rdf-schema#comment"Study found that KIR3DL2 is expressed in tissue tumor-infiltrating cells in the majority of patients with adult T-cell lymphoma/leukemia. Disease-specific survival of patients with KIR3DL2 expression > 50% was statistically significantly decreased compared with patients with KIR3DL2 expression < 5% or KIR3DL2 expression between 5% and 50%."xsd:string
http://purl.uniprot.org/uniprot/#_70E88A20916888EB1396F62D8D27CA2E919AA19CA86420395ECCA5114FA40519582E5C9F1C813D2CDF89059DA9DD19B6http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/F18112CC572C54ED4896CA2E29C728AE42B9DCBEEFC3BFEB4B72205303810671E2B2A8242E03A62BEC2DFCC98133C371
http://purl.uniprot.org/uniprot/O78200http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/F18112CC572C54ED4896CA2E29C728AE42B9DCBEEFC3BFEB4B72205303810671E2B2A8242E03A62BEC2DFCC98133C371
http://purl.uniprot.org/uniprot/#_O78200-mappedCitation-29315492http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/F18112CC572C54ED4896CA2E29C728AE42B9DCBEEFC3BFEB4B72205303810671E2B2A8242E03A62BEC2DFCC98133C371